Tissue Regenix posts loss as costs offset higher revenue

Writer, Stock Market Wire
Monday, September 3, 2018 - 09:21

Regenerative medical devices company Tissue Regenix Group posted a first-half loss, as higher revenue was offset by costs.

Pre-tax losses for the six months through June amounted to £4.3m, narrowing from £5.4m of losses on-year.

Sales increased by 61% on a pro-forma basis to £5.6m, while gross margins improved by 12.1 percentage points to 56%.

Costs related to financing, depreciation and share-based payments to executives all rose.

'We have delivered a strong first half performance,' chief executive Steve Couldwell said.

'I am pleased with the growing momentum across our business and we increased market penetration in our key clinical areas as a result of the good progress against our refined strategy.'

At 9:21am: (LON:TRX) Tissue Regenix Group PLC share price was +0.63p at 9.38p


Related content

Tissue Regenix secures additional coverage in the US for DermaPure

Tissue Regenix secured additional coverage with a US Group Purchasing Organization (GPO) for the use of DermaPure, a decellularized allograft dermis.

The company said the...

Thu, 04/04/2019 - 07:48


Tissue Regenix moves closer to profitability after revenue jumps

Regenerative medical devices company Tissue Regenix Group said it expected to move closer to its goal of generating 'sustainable profitability' in 2019 after it more...

Mon, 04/02/2019 - 14:17


Tissue Regenix signs European distribution agreement with Arthrex

Regenerative medical devices company Tissue Regenix Group said it had entered into an agreement allowing Arthrex to distribute its BioRinse bone portfolio throughout Europe, with...

Tue, 13/11/2018 - 09:19


Tissue Regenix confirms new CFO appointment

Manchester-based medical devices company Tissue Regenix Group confirmed that Gareth Jones had officially taken up the role of chief financial officer.

His appointment had been...

Mon, 29/10/2018 - 07:54


Tissue Regenix appoints Gareth Hywel Jones as CFO

Regenerative medical devices company Tissue Regenix Group said it had appointed Gareth Hywel Jones as its new chief financial officer, effective at the end of...

Wed, 04/07/2018 - 09:25